Lingang Qihang Fund
VC Fund
Lingang Qihang Fund is an invesetment fund.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Lingang Qihang Fund invests in
Stages Lingang Qihang Fund invests in
Countries Lingang Qihang Fund invests in
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Inari Medical
|
Inari Medical is dedicated to delivering comprehensive, full-process solutions for the management of bone metabolism, addressing every stage of an individual's life cycle. | Seed / Apr 22, 2026 |
Co-Investors
Bioclub
1 deal together
WEIFU GROUP
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Lingang Qihang Fund invest in?
Lingang Qihang Fund invests primarily in Medical startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Lingang Qihang Fund last invest?
The most recent investment recorded for Lingang Qihang Fund closed in Apr 2026. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
